← Open Payments lookup

KIMBERLY PURCELL-HOUCK: Open Payments

NPI 1740917129 · SALEM, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$437 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $245 · 2025 $437

Food & beverage: $437
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.4$72
ABBVIE INC.4$71
Lilly USA, LLC3$59
GlaxoSmithKline, LLC.3$55
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$42
AstraZeneca Pharmaceuticals LP2$37
Novo Nordisk Inc2$36
Otsuka America Pharmaceutical, Inc.2$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
PFIZER INC.1$14

Products named: Kerendia, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, XIFAXAN, BREZTRI, REXULTI, Ozempic.

Industry payments across MO — which companies pay providers there.